CIBC World Market
EPRX

CIBC World Market’s Eupraxia Pharmaceuticals EPRX Stock Holding History

CIBC World Market’s Portfolio EPRX Stock Details EPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.09M Buy
150,950
+92,900
+160% +$748K ﹤0.01% 909
2025
Q4 		$437K Buy
58,050
+43,050
+287% +$265K ﹤0.01% 1164
2025
Q3 		$88.4K Hold
15,000
– – ﹤0.01% 1377
2025
Q2 		$86.4K Buy
+15,000
New +$57.6K ﹤0.01% 1321

Other funds holding EPRX

BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

CIBC World Market's EPRX Position: Q1 2026 in Review

CIBC World Market increased its Eupraxia Pharmaceuticals (EPRX) stake by 160% in Q1 2026, buying an estimated $748K and bringing the position to 150,950 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #909.

CIBC World Market first reported a position in EPRX in Q2 2025 and has held it in 4 quarters since. 54 funds tracked by Wall St. Rank hold EPRX as of Q1 2026.

  • CIBC World Market held 150,950 shares of Eupraxia Pharmaceuticals worth $1.09M as of Q1 2026.
  • CIBC World Market bought 92,900 Eupraxia Pharmaceuticals shares in Q1 2026, an estimated $748K.
  • Eupraxia Pharmaceuticals made up ﹤0.01% of CIBC World Market's portfolio in Q1 2026, its #909 holding.
  • CIBC World Market first reported a position in Eupraxia Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • 54 funds tracked by Wall St. Rank held Eupraxia Pharmaceuticals as of Q1 2026.

Based on CIBC World Market's 13F filing for Q1 2026, filed 14 May 2026.